Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc-dependent enzymes and zinc-binding proteins constitute a large and diverse group of proteins where zinc ions play essential catalytic, structural, or regulatory roles (Maret, 2013, Metallomics). Zinc serves as a cofactor for approximately 10% of the human proteome, including critical enzymes such as carbonic anhydrases, matrix metalloproteinases (MMPs), and histone deacetylases (HDACs) (Andreini et al., 2006, Journal of Proteome Research). These proteins are involved in a wide array of biological processes, ranging from DNA replication and gene expression to metabolism and signal transduction (Vallee & Falchuk, 1993, Physiological Reviews). In disease states, dysregulation of zinc-binding proteins is linked to cancer, cardiovascular disorders, and neurodegeneration (Watt et al., 2010, Frontiers in Bioscience). Therapeutic strategies often involve small-molecule inhibitors that bind to the zinc ion within the protein's active site, effectively blocking its function (Chen et al., 2019, Journal of Medicinal Chemistry). However, the ubiquity of zinc-binding motifs across various protein families presents a significant challenge for drug design, as achieving high specificity is necessary to minimize adverse effects (Parkin, 2004, Chemical Communications).
Drugs typically interact with these targets by chelating the zinc ion in the active site or by displacing the water molecule coordinated to the zinc, thereby inhibiting enzymatic activity or disrupting structural motifs like zinc fingers (Chen et al., 2019, Journal of Medicinal Chemistry).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc-dependent enzymes and zinc-binding proteins.